WallStreetZenWallStreetZen

NASDAQ: OMCL
Omnicell Inc Stock

$57.54+1.74 (+3.12%)
Updated Jan 27, 2023
OMCL Price
$57.54
Fair Value Price
$61.61
Market Cap
$2.57B
52 Week Low
$46.11
52 Week High
$159.57
P/E
52.79x
P/B
2.26x
P/S
2.95x
PEG
0.3x
Dividend Yield
N/A
Revenue
$1.31B
Earnings
$48.04M
Gross Margin
47.1%
Operating Margin
3.64%
Profit Margin
3.7%
Debt to Equity
0.92
Operating Cash Flow
$55M
Beta
0.99
Next Earnings
Feb 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A

OMCL Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OMCL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OMCL ($57.54) is undervalued by 6.61% relative to our estimate of its Fair Value price of $61.61 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OMCL ($57.54) is not significantly undervalued (6.61%) relative to our estimate of its Fair Value price of $61.61 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OMCL ($57.54) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OMCL due diligence checks available for Premium users.

Be the first to know about important OMCL news, forecast changes, insider trades & much more!

OMCL News

Valuation

OMCL fair value

Fair Value of OMCL stock based on Discounted Cash Flow (DCF)
Price
$57.54
Fair Value
$61.61
Undervalued by
6.61%
OMCL ($57.54) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OMCL ($57.54) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OMCL ($57.54) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OMCL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
52.79x
Industry
17.16x
Market
23.59x
OMCL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OMCL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

OMCL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.26x
Industry
2.93x
OMCL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OMCL price to earnings growth (PEG)

For valuing profitable companies with growth potential
OMCL is good value based... subscribe to Premium to read more.
PEG Value Valuation

OMCL's financial health

Profit margin

Revenue
$348.1M
Net Income
$16.8M
Profit Margin
4.8%
OMCL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OMCL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.2B
Liabilities
$1.0B
Debt to equity
0.92
OMCL's short-term assets ($849.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OMCL's short-term assets ($849.13M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OMCL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OMCL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$21.2M
Investing
-$15.9M
Financing
$9.1M
OMCL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OMCL vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
OMCL$2.57B+3.12%52.79x2.26x
AGTI$2.46B+0.49%65.79x2.62x
PRVA$2.92B+1.63%-75.18x6.21x
GDRX$2.11B+6.61%-31.29x2.67x
PGNY$3.14B+1.17%73.57x9.06x

Omnicell Stock FAQ

What is Omnicell's quote symbol?

NASDAQ: OMCL) Omnicell trades on the NASDAQ under the ticker symbol OMCL. Omnicell stock quotes can also be displayed as NASDAQ: OMCL.

If you're new to stock investing, here's how to buy Omnicell stock.

What is the 52 week high and low for Omnicell (NASDAQ: OMCL)?

(NASDAQ: OMCL) Omnicell's 52-week high was $159.57, and its 52-week low was $46.11. It is currently -63.94% from its 52-week high and 24.79% from its 52-week low.

How much is Omnicell stock worth today?

(NASDAQ: OMCL) Omnicell currently has 44,649,842 outstanding shares. With Omnicell stock trading at $57.54 per share, the total value of Omnicell stock (market capitalization) is $2.57B.

Omnicell stock was originally listed at a price of $8.76 in Aug 9, 2001. If you had invested in Omnicell stock at $8.76, your return over the last 21 years would have been 556.85%, for an annualized return of 9.38% (not including any dividends or dividend reinvestments).

How much is Omnicell's stock price per share?

(NASDAQ: OMCL) Omnicell stock price per share is $57.54 today (as of Jan 27, 2023).

What is Omnicell's Market Cap?

(NASDAQ: OMCL) Omnicell's market cap is $2.57B, as of Jan 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Omnicell's market cap is calculated by multiplying OMCL's current stock price of $57.54 by OMCL's total outstanding shares of 44,649,842.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.